Cutler Investment Counsel’s Pfizer PFE Stock Holding History

Cutler Investment Counsel’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.93M	Sell	163,108 -9	-0%	-$235	0.37%	60
2026 Q1	$4.58M	Sell	163,117 -2,152	-1%	-$57.3K	0.47%	56
2025 Q4	$4.12M	Sell	165,269 -4,135	-2%	-$104K	0.43%	56
2025 Q3	$4.32M	Sell	169,404 -3,345	-2%	-$82.6K	0.45%	57
2025 Q2	$4.19M	Sell	172,749 -1,493	-0.9%	-$34.8K	0.47%	57
2025 Q1	$4.42M	Sell	174,242 -2,434	-1%	-$63.7K	0.53%	55
2024 Q4	$4.69M	Buy	+176,676	New	+$4.79M	0.58%	51
2023 Q2	–	Sell	-5,406	Closed	-$221K	–	129
2023 Q1	$221K	Sell	5,406 -207	-4%	-$8.94K	0.03%	125
2022 Q4	$288K	Sell	5,613 -168	-3%	-$8.05K	0.04%	112
2022 Q3	$253K	Sell	5,781 -300	-5%	-$14.6K	0.04%	111
2022 Q2	$319K	Hold	6,081	–	–	0.05%	107
2022 Q1	$315K	Buy	+6,081	New	+$316K	0.04%	115
2018 Q2	–	Sell	-7,938	Closed	-$267K	–	100
2018 Q1	$267K	Hold	7,938	–	–	0.05%	77
2017 Q4	$273K	Hold	7,938	–	–	0.05%	80
2017 Q3	$269K	Hold	7,938	–	–	0.06%	70
2017 Q2	$253K	Sell	7,938 -123	-2%	-$3.88K	0.06%	68
2017 Q1	$262K	Hold	8,061	–	–	0.06%	67
2016 Q4	$248K	Sell	8,061 -11	-0.1%	-$336	0.06%	65
2016 Q3	$259K	Sell	8,072 -15	-0.2%	-$502	0.07%	65
2016 Q2	$270K	Hold	8,087	–	–	0.08%	66
2016 Q1	$227K	Hold	8,087	–	–	0.07%	69
2015 Q4	$248K	Sell	8,087 -27	-0.3%	-$849	0.08%	58
2015 Q3	$242K	Hold	8,114	–	–	0.09%	58
2015 Q2	$258K	Hold	8,114	–	–	0.08%	59
2015 Q1	$268K	Hold	8,114	–	–	0.09%	59
2014 Q4	$240K	Hold	8,114	–	–	0.08%	61
2014 Q3	$228K	Sell	8,114 -4,152	-34%	-$117K	0.08%	56
2014 Q2	$345K	Hold	12,266	–	–	0.12%	54
2014 Q1	$374K	Hold	12,266	–	–	0.13%	53
2013 Q4	$356K	Hold	12,266	–	–	0.13%	55
2013 Q3	$334K	Hold	12,266	–	–	0.13%	54
2013 Q2	$326K	Buy	+12,266	New	+$339K	0.13%	52

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cutler Investment Counsel's PFE Position: Q2 2026 in Review

Cutler Investment Counsel reduced its Pfizer (PFE) stake by 0.01% in Q2 2026, selling an estimated $235 and leaving 163,108 shares worth $3.93M. The position accounts for 0.37% of the portfolio, ranked #60.

Cutler Investment Counsel first reported a position in PFE in Q2 2013 and has held it in 32 quarters since. The position peaked at $4.69M in Q4 2024. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Cutler Investment Counsel held 163,108 shares of Pfizer worth $3.93M as of Q2 2026.
Cutler Investment Counsel sold 9 Pfizer shares in Q2 2026, an estimated $235.
Pfizer made up 0.37% of Cutler Investment Counsel's portfolio in Q2 2026, its #60 holding.
Cutler Investment Counsel first reported a position in Pfizer in Q2 2013 and has held it in 32 quarters since.
Cutler Investment Counsel's Pfizer position peaked at $4.69M in Q4 2024.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Cutler Investment Counsel's 13F filing for Q2 2026, filed 14 Jul 2026.